Algernon Health Inc. (CSE:AGN)
0.0400
0.00 (0.00%)
At close: Mar 17, 2026
Algernon Health Market Cap
Algernon Health has a market cap or net worth of CAD 2.17 million as of March 20, 2026. Its market cap has decreased by -6.69% in one year.
Market Cap
2.17M
Enterprise Value
2.97M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since February 1, 2016, Algernon Health's market cap has decreased from 17.71M to 2.17M, a decrease of -87.77%. That is a compound annual growth rate of -18.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 2.17M | -22.39% |
| Dec 31, 2025 | 2.79M | 45.99% |
| Dec 31, 2024 | 1.91M | 50.70% |
| Dec 29, 2023 | 1.27M | -75.16% |
| Dec 30, 2022 | 5.10M | -25.66% |
| Dec 31, 2021 | 6.87M | -78.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XORTX Therapeutics | 4.46M |
| ASEP Medical Holdings | 3.56M |
| BioVaxys Technology | 3.53M |
| COSCIENS Biopharma | 3.50M |
| Cytophage Technologies | 3.38M |
| Gemina Laboratories | 3.06M |
| Appili Therapeutics | 2.65M |
| Rakovina Therapeutics | 2.11M |